BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38066448)

  • 1. Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer.
    Wang H; Chen C; Wang D; Zhu Y; Chen P
    BMC Cancer; 2023 Dec; 23(1):1210. PubMed ID: 38066448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study.
    Scarfone G; Bergamini A; Noli S; Villa A; Cipriani S; Taccagni G; Vigano' P; Candiani M; Parazzini F; Mangili G
    Gynecol Oncol; 2014 Jun; 133(3):480-4. PubMed ID: 24642093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
    Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
    Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of stage I ovarian clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a myth?
    Ayhan A; Akilli H; Haberal N
    Arch Gynecol Obstet; 2019 Jan; 299(1):217-222. PubMed ID: 30315413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
    Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of ovarian clear cell carcinoma with and without endometriosis in People's Republic of China.
    Ye S; Yang J; You Y; Cao D; Bai H; Lang J; Chen J; Shen K
    Fertil Steril; 2014 Dec; 102(6):1656-62. PubMed ID: 25256925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
    Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
    J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.
    Komiyama S; Aoki D; Tominaga E; Susumu N; Udagawa Y; Nozawa S
    Gynecol Oncol; 1999 Mar; 72(3):342-6. PubMed ID: 10053105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic transformation of benign endometriosis to early epithelial ovarian cancer.
    Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA
    Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
    Kato N; Sasou S; Motoyama T
    Mod Pathol; 2006 Jan; 19(1):83-9. PubMed ID: 16258507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice.
    Matsuo Y; Tashiro H; Yanai H; Moriya T; Katabuchi H
    Med Mol Morphol; 2015 Sep; 48(3):146-54. PubMed ID: 25398420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.
    Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
    J Ovarian Res; 2018 Aug; 11(1):67. PubMed ID: 30098603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
    Xiao W; Awadallah A; Xin W
    Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma.
    Ju UC; Kang WD; Kim SM
    Int J Gynaecol Obstet; 2019 Aug; 146(2):177-183. PubMed ID: 31081117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics.
    Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G
    Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953
    [No Abstract]   [Full Text] [Related]  

  • 18. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis.
    Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S
    Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characteristics of ovarian carcinomas associated with endometriosis.
    Kondi-Pafiti A; Papakonstantinou E; Iavazzo C; Grigoriadis C; Salakos N; Gregoriou O
    Arch Gynecol Obstet; 2012 Feb; 285(2):479-83. PubMed ID: 21717140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.